BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence
Chemical Engineering Journal · 2024-09 · 496 · 154208
DOI: 10.1016/j.cej.2024.154208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-09. Verfasst von Rong Huang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Ministry of Science and Technology of the People's Republic of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Huang, R., Lin, C., Jiang, G., Zhang, M., Gao, W., Aihemaiti, K., Liu, Q., Shi, J., Shi, W., & Huang, R. (2024). BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence. Chemical Engineering Journal, 496, 154208. https://doi.org/10.1016/j.cej.2024.154208
Vancouver
Huang R, Lin C, Jiang G, Zhang M, Gao W, Aihemaiti K, et al. BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence. Chemical Engineering Journal. 2024;496:154208. doi:10.1016/j.cej.2024.154208
BibTeX
@article{Huang2024,
author = {Huang, Rong and Lin, Chenteng and Jiang, Guangwei and Zhang, Meng and Gao, Wenjia and Aihemaiti, Kamiran and Liu, Qianqian and Shi, Jinlong and Shi, Wei and Huang, Rongqin},
title = {BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence},
journal = {Chemical Engineering Journal},
year = {2024},
volume = {496},
pages = {154208},
doi = {10.1016/j.cej.2024.154208}
}
EUVIMED